glp-1 news 2025 october 16 Beyond GLP-1: the next wave of weight-loss medication innovation GLP-1 Drug Pipeline 2026 |

Comparative efficacy, tolerability, and acceptability of donanemab, lecanemab, aducanumab, melatonin, and aerobic exercise for a short time on cognitive function in mild cognitive impairment and mild Alzheimer's disease: a systematic review and network meta-analysis

Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM

Lower blood volume means your heart works harder to deliver oxygen to tissues

Active ingredients like semaglutide, tirzepatide, or liraglutide can make your body think that GLP-1 levels are lasting longer than they usually would

But those taking orforglipron experienced much less weight regain